About the Program
To view the programs, please read the following information and scroll to the bottom of the page.
Program Overview
This program is sponsored for CME credit by The Johns Hopkins University School of Medicine and is available for clinicians interested in the latest conference updates regarding the clinical care and management of HIV-positive patients. The information in this educational activity was planned and produced in accordance with ACCME Essentials. The content consists of newsletters, a slide deck and a downloadable podcast, all prepared by a distinguished faculty. This program is for health care providers who treat HIV-positive patients and there are no prerequisites.
Presented By:
Supported by an educational grant from Merck & Co.
Back to Top
Learning Objectives and Program Details
Upon completion of this CME activity, the participant should be able to:
• Understand, describe and explain the key new studies presented at the 48th ICAAC/46th IDSA and/or HIV-9 on the treatment of HIV
• Use the advances in clinical management of HIV-positive patients presented and discussed at the 48th ICAAC/46th IDSA and/or HIV-9 to improve patient care
• Analyze and apply data presented and discussed at the 48th ICAAC/46th IDSA and/or HIV-9 regarding the treatment of ARV-experienced patients to analyze treatment options and construct appropriate ARV regimens
Release Date: November 24, 2008
Expiration Date: November 24, 2009
Estimated time to complete this activity:
• ICAAC/IDSA Newsletter 1.0 hour
• HIV-9 Newsletter 1.0 hour
• Combined ICAAC/IDSA and HIV-9 Slide Deck 1.0 hour
• Combined ICAAC/IDSA and HIV-9 Podcast 1.0 hour
The Johns Hopkins University School of Medicine takes responsibliity for the content, quality, and scientific integrity of the CME activity
Back to Top
Intended Audience
This activity is intended for physicians, physicians' assistants, and advanced practice nurses and other healthcare professionals involved in the treatment and management of patients with HIV infection. There are no prerequisites.
Back to Top
Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Back to Top
Credit Designation Statement
Newsletter 48th ICAAC/46th IDSA
The John Hopkins University School of Medicine designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Newsletter HIV-9
The John Hopkins University School of Medicine designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Podcast 48th ICAAC/46th IDSA and HIV-9
The John Hopkins University School of Medicine designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Slide Deck 48th ICAAC/46th IDSA and HIV-9
The John Hopkins University School of Medicine designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Back to Top
CME Course Director
John Bartlett, MD
Professor of Medicine
The Johns Hopkins University School of Medicine
Baltimore, MD
Back to Top
Faculty
John Bartlett, MD
Professor of Medicine
The Johns Hopkins University School of Medicine
Baltimore, MD
Calvin J. Cohen, MD, MS
Research Director, CRI New England
Clinical Instructor, Harvard Medical School
Boston, MA
David Cooper, MD
Professor of Medicine at the University of New South Wales
Director of The National Centre in HIV Epidemiology and Clinical Research
Sydney, Australia
Edwin DeJesus, MD
Medical Director
Orlando Immunology Center
Orlando, FL
Richard A. Elion, MD
Associate Professor of Clinical Medicine
George Washington University
Washington, DC
Graeme J. Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, UK
Jurgen Rockstroh, MD
Professor of Medicine and Head of HIV Outpatient Clinic
University of Bonn
Bonn, Germany
Paul Sax, MD
Clinical Director
Division of Infectious Diseases and HIV Program
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Mauro Schechter, MD, PhD
Head, AIDS Research Laboratory
Universidade Federal do Rio de Janeiro
Rio de Janeiro, Brazil
Back to Top
Instructions for Obtaining Continuing Medical Education Credit
In order to receive credit for each activity, participants must view the entire activity and complete a post test and activity evaluation online. Upon a successful score of 70% on the post test and completion of the evaluation, participants may print our their certificate. Participants may access the post test and evaluation here.
Back to Top
Faculty Disclosure
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following disclosure information:
Dr. John Bartlett:
• Sources: Gilead
• Consulting Agreements: Bristol-Myers Squibb, Tibotec, Abbott, GlaxoSmithKline
• Speakers' Bureau/Honorarium Agreements: None
• Financial Interests/Stock Ownership: None
• Other: None
Dr. Calvin Cohen:
• Sources of Funding for Research: Abbott; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Roche; Pfizer; Tibotec.
• Consulting Agreements: Abbott; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Roche; Pfizer; Tibotec.
• Speakers' Bureau/Honorarium Agreements: Abbott; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Roche; Pfizer; Tibotec; Virco.
• Financial Interests/Stock Ownership: None.
• Other: ViralEd, LLC.
Dr. David Cooper:
• Sources of Funding for Research: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Tibotec; Pfizer; Merck; Avexa; Boehringer Ingelheim; Abbott.
• Consulting Agreements: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Pfizer; Merck; Avexa; Boehringer Ingelheim; Abbott; Tibotec.
• Speakers' Bureau/Honorarium Agreements: Bristol-Myers Squibb; Gilead; Pfizer; Merck; Avexa; Boehringer Ingelheim; Abbott; Tibotec.
• Financial Interests/Stock Ownership: None.
Dr. Edwin DeJesus:
• Sources of Funding for Research: Boehringer Ingelheim; Abbott; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Roche; Pfizer; Tibotec; Merck; Schering Plough.
• Consulting Agreements: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Roche; Vertex.
• Speakers' Bureau/Honorarium Agreements: Boehringer Ingelheim; Abbott; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Roche; Pfizer; Tibotec; Schering Plough.
• Financial Interests/Stock Ownership: None.
Dr. Richard A. Elion:
• Sources of Funding for Research: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Incyte; Tibotec.
• Consulting Agreements: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Incyte; Panacos.
• Speakers' Bureau/Honorarium Agreements: None.
• Financial Interests/Stock Ownership: None.
• Other: ViralEd, LLC.
Dr. Graeme Moyle:
• Sources of Funding for Research: Abbott; Arnomed; Ardea; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Pfizer; Tibotec.
• Consulting Agreements: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Pfizer; Panacos; Tobira; Tibotec.
• Speakers' Bureau/Honorarium Agreements: Bristol-Myers Squibb; Boehringer-Ingelheim; Gilead; GlaxoSmithKline; Merck; Pfizer; Tibotec.
• Financial Interests/Stock Ownership: None.
• Other: ViralEd, LLC.
Dr. Jurgen Rockstroh:
• Sources of Funding for Research: Abbott; Roche.
• Consulting Agreements: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Pfizer; Tibotec; Roche; Vertex; Boehringer Ingelheim; Abbott.
• Speakers' Bureau/Honorarium Agreements: Bristol-Myers Squibb; Boehringer-Ingelheim; Gilead; GlaxoSmithKline; Merck; Pfizer; Tibotec; Roche; Vertex; Abbott.
• Financial Interests/Stock Ownership: None.
Dr. Paul Sax:
• Sources of Funding for Research: Bristol-Myers Squibb; Merck; Pfizer.
• Consulting Agreements: Abbott; Bristol-Myers Squibb; Gilead; GlaxoSmithKline.
• Speakers' Bureau/Honorarium Agreements: Abbott; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Tibotec; Virco.
• Financial Interests/Stock Ownership: None.
• Other: None.
Dr. Mauro Schechter:
• Sources of Funding for Research: Gilead; GlaxoSmithKline; Bristol-Myers Squibb; Roche; Merck; Boehringer Ingelheim; Abbott.
• Consulting Agreements: Bristol-Myers Squibb; Gilead; Pfizer; Merck; Abbott; GlaxoSmithKline.
• Speakers' Bureau/Honorarium Agreements: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Abbott; Pfizer.
• Financial Interests/Stock Ownership: None.
No speaker has indicated that their presentation will include information on off-label products.
Back to Top
View Programs
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients. The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME program. CME collects only the information necessary to provide you with the services that you request. Copyright © 2008 The Johns Hopkins University School of Medicine. All rights reserved.
Back to Top
|
